Axogen Inc

LT3

Company Profile

  • Business description

    Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.

  • Contact

    13631 Progress Boulevard
    Suite 400
    AlachuaFL32615
    USA

    T: +1 386 462-6800

    E: [email protected]

    https://www.axogeninc.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    622

Stocks News & Analysis

stocks

ASX healthcare leader sees further cuts to fair value

Fiercer competition expected to squeeze margins.
stocks

Avoid this overpriced ASX share

This ASX share is 84% overvalued and lacks a sustainable competitive advantage.
stocks

Markets brief: How will AI affect economic moats? Morningstar’s take on the new paradigm

A broad assessment of AI’s threats and opportunities leads to moat ratings changes for more than three dozen companies.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,970.2014.100.16%
CAC 408,052.4358.940.74%
DAX 4023,968.63559.262.39%
Dow JONES (US)47,706.5134.29-0.07%
FTSE 10010,409.53160.011.56%
HKSE25,959.90202.610.79%
NASDAQ22,697.101.160.01%
Nikkei 22555,259.441,011.051.86%
NZX 50 Index13,262.67168.301.29%
S&P 5006,781.4814.51-0.21%
S&P/ASX 2008,739.1015.000.17%
SSE Composite Index4,123.1426.540.65%

Market Movers